help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on January 10, 2008, doi:10.1165/rcmb.2007-0224RC

Am. J. Respir. Cell Mol. Biol., Volume 38, Number 4, April 2008, 380-385

A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0224RCv1
38/4/380    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, J.
Right arrow Articles by Fine, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, J.
Right arrow Articles by Fine, A.

Submitted on June 14, 2007
Revised on January 9, 2008

The Prolonged Life-Span of Alveolar Macrophages

Jaime Murphy1*, Ross Summer1, Andrew A Wilson1, Darrell N Kotton1, and Alan Fine1

1 Boston University School of Medicine, The Pulmonary Center, Boston, Massachusetts, USA

* To whom correspondence should be addressed. E-mail: murphj04{at}bu.edu.

To further examine the half-life of alveolar macrophages, chimeric CD 45.2 mice were generated through bone marrow transplantation of donor CD 45.1 cells. Prior to administration of donor cells, recipient mice were divided into 2 cohorts: the first cohort received total body irradiation, the second cohort also received irradiation, however, their thorax, head, and upper extremities were shielded with lead. Flow cytometric analysis was then performed on blood, peritoneal and bronchoalveolar lavage cells over time to quantify engraftment. The data generated for the unshielded cohort of mice revealed a macrophage half-life of 30 days. In the shielded cohort, however, we found that by 8 months there was negligible replacement of recipient alveolar macrophages by donor cells, despite reconstitution of the blood and peritoneum by donor bone marrow. Consistent with these findings, the mean fluorescent intensity of alveolar macrophages remained stable over a 4 week period after in vivo PKH26 dye loading. Together, these data show that previous alveolar macrophage half-life studies were confounded by the fact that they did not account for the toxic effects of irradiation conditioning regimens, and demonstrate that the bone marrow does not significantly contribute to the alveolar macrophage compartment during steady-state conditions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society.